NEU

NEUREN PHARMACEUT.

• The Motley Fool·6d ago

  CSL shares fall on new Trump tariff hit

• ASX·09/21 21:31

  Notification regarding unquoted securities - NEU

• The Motley Fool·09/19 04:20

  Life360 and Neuren Pharmaceuticals among 9 ASX 200 shares hitting multi-year highs

• The Motley Fool·09/19 02:02

  Expert names 2 ASX healthcare stocks to buy in September

• ASX·09/09 00:00

  Director Conflict Of Interest Policy

• ASX·09/08 09:09

  Change of Director's Interest Notice

• The Motley Fool·08/31 23:12

  Macquarie tips 12% return for this ASX 200 healthcare stock

• Dow Jones·08/29 06:26

  *Neuren Pharmaceuticals Price Target Raised 14% to A$21.20/Share by Macquarie

• ASX·08/28 06:44

  Application for quotation of securities - NEU

• Dow Jones·08/27 22:00

  *Neuren Pharmaceuticals Price Target Raised 0.4% to A$28.60/Share by Jefferies

• ASX·08/27 00:00

  H1 2025 profit after tax A$15m, up from A$8m in H1 2024 2025 Corporate Governance Statement and Appendix 4G

• ASX·08/26 23:21

  Half Yearly Report and Accounts

• ASX·08/24 23:29

  First site initiated for Neuren's PMS Phase 3 trial

• ASX·08/12 06:13

  Application for quotation of securities - NEU

• The Motley Fool·08/11 21:33

  Why this ASX 200 stock could jump 25%